NASDAQ:PSTV

Plus Therapeutics Stock Predictions

etoro logo Buy PSTV
*Your capital is at risk
$5.42
-0.0500 (-0.91%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

PSTV Prediction Chart

PSTV Predictions History

Latest community submissions for PSTV.
Predictor Target Session Target Price Result Direction Accuracy Score
Nov 25, 2025 Bullish $0.561 X 0
Nov 25, 2025 Bullish $0.561 X 0
Nov 24, 2025 $0.510 -96.17% $0.575 V 88.68% 0
Nov 24, 2025 $0.519 -96.11% $0.575 V 90.16% 0
Nov 24, 2025 Bullish $0.575 X 1
Oct 17, 2025 $0.650 -95.77% $0.620 X 95.16% 1
Oct 17, 2025 $0.637 -95.85% $0.620 X 97.33% 1
Oct 17, 2025 Bullish $0.620 X 1
Tenaya Adrean Tenaya Adrean @TenayaAdrean.250731
Oct 7, 2025 Bullish $0.82 X 0
Oct 3, 2025 $0.718 -95.79% $0.731 X 98.19% 1
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for PSTV with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT PLUS THERAPEUTICS, INC.
Plus Therapeutics
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacture, and commercialization of treatments for patients with cancer and other diseases. Its lead drug candidate is Rhenium-186 NanoLiposome, a patented radiotherapy that targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. It has a license agreement with NanoTx, Corp. to d...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE